Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations
Document Type
Article
Publication Date
4-28-2020
Publication Title
Abstract
Randomization is the foundation of any randomized controlled trial involving treatment comparisons. The major benefits of randomization in the context of clinical trials are:
- Randomization helps mitigate various experimental biases.
- It promotes comparability of treatment groups with respect to important known and unknown prognostic factors that may be correlated with the primary outcome.
- It is the basis for the validity of standard statistical tests and makes the underlying assumptions of random sampling more plausible.
- It can form the basis for statistical inference through re-randomization tests.
Recommended Citation
Liu, Qing, Karl E. Peace.
2020.
"Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations."
LinkedIn.
source: Linkedin.com
https://digitalcommons.georgiasouthern.edu/bee-facpubs/149